Group 1 - The article discusses two new IPOs: Yisiwei (科创板, 688816) and Aide Technology (北交所, 92018) [2][3] - Yisiwei has a total market value of 4.196 billion and an issuance price-earnings ratio of 90.39, with a significant focus on machine vision equipment in the automotive manufacturing sector [2][3] - Aide Technology has a total market value of 679.5 million and an issuance price-earnings ratio of 14.98, primarily engaged in orthopedic consumables and medical device R&D [3][4] Group 2 - Yisiwei's revenue for the past three years shows a growth trend, with projected revenue of 392 million in 2024 (+10.58%) and a notable increase in net profit in 2023 (+58.98%) [3] - Aide Technology's revenue for the past three years indicates a slight decline in 2023 (-8.39%), with projected revenue of 301 million in 2025 (+9.45%) [4] - Both companies are focusing on expanding their production capabilities and R&D centers, with Yisiwei targeting machine vision product industrialization and Aide Technology focusing on orthopedic consumables expansion [3][4]
【2月2日IPO雷达】易思维、爱得科技申购
Xuan Gu Bao·2026-02-02 00:02